Longport Stock

Longport ROE

The Return on Equity (ROE) of Longport (LPTI) as of Aug 15, 2026 is -70.09 %.

ROE

-70.09 %

Last updated:

In 2026, Longport's return on equity (ROE) was -70.09 %, a % increase from the - ROE in the previous year.

Access this data via the Eulerpool API

Longport Stock analysis

What does Longport do? Longport Inc is a US-based company specializing in the development, manufacturing, and marketing of medical devices. It was founded in 1998 by a group of engineers and businesspeople with a vision to create devices that make medical treatments more effective and safer. The business model of Longport Inc is based on providing customized solutions for medical applications. The company offers a wide range of products and services focusing on various medical fields such as radiology, urology, neurology, gastroenterology, and cardiology. Another focus is on developing products for the treatment of vascular diseases. The company follows a customer-oriented philosophy tailored to the needs of its customers. It works closely with hospitals and other healthcare facilities and has built partnerships with medical device companies worldwide. Longport Inc is headquartered in New Jersey, USA, and has branches in Europe and Asia. It employs a wide range of professionals including engineers, scientists, salespeople, and managers. In terms of its various product divisions, Longport Inc is best known for its medical imaging products. The company has developed a range of products that contribute to improving the accuracy and effectiveness of X-ray and ultrasound images. These include image processing software, detectors, and other accessories. In urology, Longport Inc has developed a wide range of products supporting the diagnosis and treatment of prostate diseases. This includes devices such as the transrectal ultrasound probe and the prostate biopsy needle. In neurology, the company offers devices for the diagnosis and treatment of brain injuries and diseases. These range from stereotactic devices used for deep brain stimulation procedures to devices used for measuring brain waves. In the field of gastroenterology, Longport Inc provides products for the diagnosis and treatment of gastrointestinal inflammation, as well as for the treatment of stomach ulcers and other stomach issues. Finally, the company also develops products for other medical applications beyond its core areas. These include devices for monitoring blood pressure, measuring blood glucose levels, and treating heart diseases. Over the years, Longport Inc has received several awards for its innovative products and exceptional achievements in the field of medical device manufacturing. The company is committed to continuing to develop innovative solutions for the medical industry to improve patient treatment worldwide. Longport is one of the most popular companies on Eulerpool.

ROE Details

Decoding Longport's Return on Equity (ROE)

Longport's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Longport's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Longport's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Longport’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Longport stock

Return on Equity (ROE) of Longport is -70.09 % in 2026.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Longport since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Longport with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Longport

All Key Metrics — Longport